NURIX THERAPEUTICS INC. - COMMON STOCK

18.59

04-February-25 16:45:00

15 minutes delayed

Stocks

-0.36

-1.90%

Today's range

18.29 - 19.36

ISIN

N/A

Source

NASDAQ

Nurix Therapeutics Announces Presentation of NX-1607 Preclinical Data at AACR

10 Mar 2021 17:12:18 By Nasdaq GlobeNewswire
Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

09 Mar 2021 16:01:00 By Nasdaq GlobeNewswire
Nurix Therapeutics to Participate and Present at Upcoming Investor Conferences

09 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

04 Mar 2021 20:01:29 By Nasdaq GlobeNewswire
Nurix Therapeutics Announces Launch of Proposed Public Offering of Common Stock

02 Mar 2021 16:15:45 By Nasdaq GlobeNewswire
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update

16 Feb 2021 16:01:00 By Nasdaq GlobeNewswire
Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies

07 Jan 2021 07:00:00 By Nasdaq GlobeNewswire

<<
<
3
4
5
6
7
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.